Goldman's Kostin Sees Fed Cutting Rates Three Times

Posted Jul 9 by Two Blokes

David Kostin, Goldman Sachs US chief equity strategist, says the clarity from the passage of the federal spend

Source: Two Blokes Trading

Devon is Trading Above 50 and 200 Day SMA: How to Play the Stock?

Posted Jul 9 by Two Blokes

DVN trades above 50 and 200 Day SMAs, signaling a bullish trend backed by strong assets, low costs and discoun

Source: Two Blokes Trading

Goldman's Kostin Sees Fed Cutting Rates Three Times

Posted Jul 9 by Two Blokes

David Kostin, Goldman Sachs US chief equity strategist, says the clarity from the passage of the federal spend

Source: Two Blokes Trading

Gilat Satellite: The Market Is Yet To Price In Its Solid Fundamentals

Posted Jul 9 by Two Blokes

Gilat's sidewinder antennas are seeing great reception from big IFC providers like Intelsat and Panasonic. The

Source: Two Blokes Trading

Tariff-driven inflation is likely to hit in the second half, expert says

Posted Jul 9 by Two Blokes

Tariff-driven inflation isn't showing up in the data just yet, but Dana Peterson, Chief Economist, The Confere

Source: Two Blokes Trading

Pump.fun faces scrutiny over PUMP token distribution in upcoming ICO

Posted Jul 9 by Two Blokes

Solana-based memecoin launchpad Pump.fun has confirmed that its native PUMP token will debut through an Initia

Source: Two Blokes Trading

Two Republicans named Kevin are vying to be the next Fed chair: rising contender Kevin Hassett, and Kevin Warsh, an early favori

Posted Jul 9 by Two Blokes

Kevin Hassett has emerged as a serious contender to succeed Jerome Powell, posing a possible threat to Kevin W

Source: Two Blokes Trading

President Trump decided to delay the implementation of his so-called reciprocal tariffs to Aug. 1 after advisers including Treas

Posted Jul 9 by Two Blokes

The president also decided to send out letters as a way to keep the pressure up.

Source: Two Blokes Trading

Here's Why You Should Add PacBio Stock to Your Portfolio Now

Posted Jul 9 by Two Blokes

PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic con

Source: Two Blokes Trading

RXRX Stock Up on Acquiring Full Rights to the Hypophosphatasia Program

Posted Jul 9 by Two Blokes

Recursion Pharmaceuticals stock jumps after securing full rights to REV102, aiming to fast-track the first ora

Source: Two Blokes Trading

Dolby Laboratories: 2025 Update Shows Buying Opportunity (Rating Upgrade)

Posted Jul 9 by Two Blokes

Dolby Laboratories, Inc. is now attractively valued, with a forward P/E below 20x and a 1.77% dividend yield,

Source: Two Blokes Trading

Do They Know Something? Insiders & Congress Buy UnitedHealth

Posted Jul 9 by Two Blokes

Let's get the bad news out of the way first. The Eden Prairie, Minn.

Source: Two Blokes Trading